IL-38: A new factor in rheumatoid arthritis

Biochemistry and Biophysics Reports

Volumn 4, Issue , 2015, Pages 386-391

  Takenaka, Shin Ichi ^a   Kaieda, Shinjiro ^a   Kawayama, Tomotaka ^a   Matsuoka, Masanobu ^a   Kaku, Yoichiro ^a   Kinoshita, Takashi ^a   Sakazaki, Yuki ^a   Okamoto, Masaki ^a   Tominaga, Masaki ^a   Kanesaki, Katsuya ^b   Chiba, Asako ^c   Miyake, Sachiko ^c   Ida, Hiroaki ^a   Hoshino, Tomoaki ^a,d  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagata Orthopedic Hospital   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

IL 1 family; IL 38; RA mouse model

Indexed keywords

EID: 84946736161     PISSN: None     EISSN: 24055808     Source Type: Journal    
DOI: 10.1016/j.bbrep.2015.10.015     Document Type: Article

References (21)

1. Lin H., Ho A.S., Haley-Vicente D., Zhang J., Bernal-Fussell J., Pace A.M., Hansen D., Schweighofer K., Mize N.K., Ford J.E. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J. Biol. Chem. 2001, 276:20597-20602.
2. Bensen J.T., Dawson P.A., Mychaleckyj J.C., Bowden D.W. Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14. J. Interferon Cytokine Res. 2001, 21:899-904.
3. van de Veerdonk F.L., Stoeckman A.K., Wu G., Boeckermann A.N., Azam T., Netea M.G., Joosten L.A., van der Meer J.W., Hao R., Kalabokis V., Dinarello C.A. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc. Natl. Acad. Sci. USA 2012, 109:3001-3005.
4. Hoshino T., Nakamura H., Okamoto M., Kato S., Araya S., Nomiyama K., Oizumi K., Young H.A., Aizawa H., Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am. J. Respir. Crit. Care Med. 2003, 168:1075-1083.
5. Kitasato Y., Hoshino T., Okamoto M., Kato S., Koda Y., Nagata N., Kinoshita M., Koga H., Yoon D.Y., Asao H., Ohmoto H., Koga T., Rikimaru T., Aizawa H. Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2004, 31:619-625.
6. Hoshino T., Okamoto M., Sakazaki Y., Kato S., Young H.A., Aizawa H. Role of proinflammatory cytokines IL-18 and IL-1beta in bleomycin-induced lung injury in humans and mice. Am. J. Respir. Cell Mol. Biol. 2009, 41:661-670.
7. Hoshino T., Yamada A., Honda J., Imai Y., Nakao M., Inoue M., Sagawa K., Yokoyama M.M., Oizumi K., Itoh K. Tissue-specific distribution and age-dependent increase of human CD11b+ T cells. J. Immunol. 1993, 151:2237-2246.
8. Omoto Y., Tokime K., Yamanaka K., Habe K., Morioka T., Kurokawa I., Tsutsui H., Yamanishi K., Nakanishi K., Mizutani H. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J. Immunol. 2006, 177:8315-8319.
9. Bae S., Kang T., Hong J., Lee S., Choi J., Jhun H., Kwak A., Hong K., Kim E., Jo S., Kim S. Contradictory functions (activation/termination) of neutrophil proteinase 3 enzyme (PR3) in interleukin-33 biological activity. J. Biol. Chem. 2012, 287:8205-8213.
10. Oda H., Kawayama T., Imaoka H., Sakazaki Y., Kaku Y., Okamoto M., Kitasato Y., Edakuni N., Takenaka S., Yoshida M., Iwanaga T., Kato S., O'Byrne P.M., Hoshino T. Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma. Ann. Allergy Asthma Immunol. 2014, 112. 23-28 e21.
11. Maccioni M., Zeder-Lutz G., Huang H., Ebel C., Gerber P., Hergueux J., Marchal P., Duchatelle V., Degott C., van Regenmortel M., Benoist C., Mathis D. Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. 2002, 195:1071-1077.
12. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692.
13. Kaieda S., Tomi C., Oki S., Yamamura T., Miyake S. Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthritis Rheum. 2007, 56:1836-1845.
14. Pettit A.R., Ji H., von Stechow D., Muller R., Goldring S.R., Choi Y., Benoist C., Gravallese E.M. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am. J. Pathol. 2001, 159:1689-1699.
15. Kaieda S., Shin K., Nigrovic P.A., Seki K., Lee R.T., Stevens R.L., Lee D.M. Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1). J. Biol. Chem. 2010, 285:21478-21486.
16. Kaieda S., Wang J.X., Shnayder R., Fishgal N., Hei H., Lee R.T., Stevens R.L., Nigrovic P.A. Interleukin-33 primes mast cells for activation by IgG immune complexes. PLOS One 2012, 7:e47252.
17. Sakazaki Y., Hoshino T., Takei S., Sawada M., Oda H., Takenaka S., Imaoka H., Matsunaga K., Ota T., Abe Y., Miki I., Fujimoto K., Kawayama T., Kato S., Aizawa H. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLOS One 2011, 6:e24177.
18. Kawayama T., Okamoto M., Imaoka H., Kato S., Young H.A., Hoshino T. Interleukin-18 in pulmonary inflammatory diseases. J. Interferon Cytokine Res. 2012, 32:443-449.
19. Ji H., Pettit A., Ohmura K., Ortiz-Lopez A., Duchatelle V., Degott C., Gravallese E., Mathis D., Benoist C. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 2002, 196:77-85.
20. Horai R., Saijo S., Tanioka H., Nakae S., Sudo K., Okahara A., Ikuse T., Asano M., Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 2000, 191:313-320.
21. Garlanda C., Dinarello C.A., Mantovani A. The interleukin-1 family: back to the future. Immunity 2013, 39:1003-1018.